EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+11.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Top Buys
| 1 |
Futu Holdings
FUTU
|
$31.5M |
| 2 |
Applied Materials
AMAT
|
$29.1M |
| 3 |
Apple
AAPL
|
$15.5M |
| 4 |
Microsoft
MSFT
|
$12.6M |
| 5 |
NVIDIA
NVDA
|
$11.6M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$28.5M |
| 2 |
TSMC
TSM
|
$15.1M |
| 3 |
KE Holdings
BEKE
|
$11.9M |
| 4 |
ASE Group
ASX
|
$7.99M |
| 5 |
Yum China
YUMC
|
$5.17M |
Sector Composition
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
NXP Semiconductors
NXPI
$56.8B
| $1.39M | 0.08% |
5,155
+865
| +20% | +$233K |
|
102
Sarepta Therapeutics
SRPT
$1.93B
| $1.38M | 0.08% |
8,761
+5,276
| +151% | +$834K |
|
103
Booking.com
BKNG
$181B
| $1.35M | 0.07% |
340
+2
| +0.6% | +$7.92K |
|
104
O'Reilly Automotive
ORLY
$89.1B
| $1.33M | 0.07% |
18,855
+10,110
| +116% | +$712K |
|
105
Cullinan Oncology
CGEM
$408M
| $1.3M | 0.07% |
+74,827
| New | +$1.3M |
|
106
Wells Fargo
WFC
$262B
| $1.3M | 0.07% |
21,947
+1,944
| +10% | +$115K |
|
107
Abbott
ABT
$231B
| $1.3M | 0.07% |
12,487
+1,413
| +13% | +$147K |
|
108
United Therapeutics
UTHR
$17.2B
| $1.24M | 0.07% |
3,908
+2,125
| +119% | +$677K |
|
109
Royal Caribbean
RCL
$97.8B
| $1.23M | 0.07% |
7,700
| – | – |
|
110
Incyte
INCY
$16.7B
| $1.23M | 0.07% |
20,240
+9,733
| +93% | +$590K |
|
111
Roper Technologies
ROP
$56.7B
| $1.22M | 0.07% |
2,158
+370
| +21% | +$209K |
|
112
Alnylam Pharmaceuticals
ALNY
$59.4B
| $1.2M | 0.07% |
4,926
+2,112
| +75% | +$513K |
|
113
Fate Therapeutics
FATE
$112M
| $1.17M | 0.06% |
355,225
+320,745
| +930% | +$1.05M |
|
114
Pfizer
PFE
$140B
| $1.16M | 0.06% |
41,469
+3,683
| +10% | +$103K |
|
115
McDonald's
MCD
$226B
| $1.14M | 0.06% |
4,483
+476
| +12% | +$121K |
|
116
Exact Sciences
EXAS
$9.73B
| $1.14M | 0.06% |
26,879
+19,661
| +272% | +$831K |
|
117
Walt Disney
DIS
$214B
| $1.13M | 0.06% |
11,395
+1,267
| +13% | +$126K |
|
118
BioMarin Pharmaceuticals
BMRN
$10.9B
| $1.11M | 0.06% |
13,480
+8,438
| +167% | +$695K |
|
119
Verizon
VZ
$186B
| $1.08M | 0.06% |
26,212
+2,997
| +13% | +$124K |
|
120
Natera
NTRA
$22.9B
| $1.08M | 0.06% |
9,979
+5,113
| +105% | +$554K |
|
121
Viking Therapeutics
VKTX
$2.98B
| $1.08M | 0.06% |
20,380
+14,342
| +238% | +$760K |
|
122
Autodesk
ADSK
$68.1B
| $1.07M | 0.06% |
4,323
+758
| +21% | +$188K |
|
123
Nike
NKE
$111B
| $1.06M | 0.06% |
14,084
| – | – |
|
124
Caterpillar
CAT
$197B
| $1.03M | 0.06% |
3,091
+2,321
| +301% | +$773K |
|
125
ICICI Bank
IBN
$114B
| $1.03M | 0.06% |
35,624
+13,905
| +64% | +$401K |
|